Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 19, 2021 08:30 ET | Source: RenovaCare, Inc.

RenovaCare to Present at Noble Capital Markets Annual Investor Conference on January 19, 2021

ROSELAND, N.J., Jan. 19, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
January 08, 2021 08:30 ET | Source: RenovaCare, Inc.

RenovaCare to Present at H.C. Wainwright BioConnect 2021 Conference

ROSELAND, N.J., Jan. 08, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
December 22, 2020 08:00 ET | Source: RenovaCare, Inc.

RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook

ROSELAND, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
November 19, 2020 08:15 ET | Source: RenovaCare, Inc.

RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones

ROSELAND, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
October 22, 2020 16:35 ET | Source: RenovaCare, Inc.

RenovaCare to Commence Investor Business and Financial Presentations; Webcast on October 29, 2020

ROSELAND, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
October 05, 2020 16:28 ET | Source: RenovaCare, Inc.

RenovaCare Elects Alan L. Rubino to Chairman of the Board of Directors

ROSELAND, N.J., Oct. 05, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other...
September 15, 2020 08:30 ET | Source: RenovaCare, Inc.

RenovaCare to Present at BioNJ/JP Morgan/J&J BioPartnering Conference

ROSELAND, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
August 11, 2020 08:30 ET | Source: RenovaCare, Inc.

RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility

ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
August 04, 2020 08:30 ET | Source: RenovaCare, Inc.

RenovaCare Appoints Dr. Lydia M. Evans to Its Board of Directors and Increases Board Membership

ROSELAND, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
July 01, 2020 08:30 ET | Source: RenovaCare, Inc.

RenovaCare Launches R&D Innovation Center (Berlin) for Organ & Tissue Regeneration

ROSELAND, N.J., July 01, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced the official launch of its new RenovaCare R&D Innovation Center in...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right